Drug intelligence / Profile preview

cocaine

Development stage
Approved
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Intranasal, Inhalation, Intravenous, Topical, Oral
01

Overview

Cocaine is a tropane alkaloid and a powerful central nervous system stimulant derived from the leaves of the coca plant native to South America. It is most commonly encountered as an illicit recreational drug but has limited medical use as a local anesthetic in certain surgical procedures. Cocaine acts primarily by blocking the reuptake of monoamine neurotransmitters—dopamine, norepinephrine, and serotonin—by inhibiting their respective transporters in the brain. This leads to increased concentrations of these neurotransmitters in synaptic clefts and results in heightened alertness, euphoria, increased energy, and strong addictive potential. The blockade of dopamine reuptake is considered especially important for its rewarding effects and high abuse liability[1][2][4][5][6][8].

Brand names
RX0041-002RX-0041-002RX 0041-002
Other names
benzoylmethylecgoninecrackcokesnowblow
02

Targets

DAT (Dopamine plasma membrane transport protein)NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)HTR3A (5-hydroxytryptamine receptor 3A)

Beyond the preview

Go deeper on cocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cocaine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call